Huntington’s Disease Treatment Market

Huntington’s Disease Treatment Market Size by Drug Type (Antidepressants, Tetrabenazine, Tranquilizers, Antipsychotic Drugs, and Others), By Treatment (Disease-Modifying Therapies and Symptomatic Treatment), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-12679
  • Published Date: Mar, 2022
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global Huntington’s disease treatment market is expected to reach USD 1812.15 million by 2030, at a CAGR of 19.2% from 2022 to 2030. The demand for Huntington's disease treatment has grown fast in recent years, and it is expected to grow much more throughout the forecast period. This expansion can be attributed to substantial R&D spending for product innovation, scientific collaborations, and the large HD load in Western nations. Huntington's disease is a disorder in which cells of central nervous system stops working that affects multiple generations. It primarily affects persons aged 30 to 50, affecting their opportunity to function, care for their households, and, ultimately, accomplish everyday duties.

Market Overview:

Huntington's disease (HD) is a genetic central nervous system condition. The condition causes the brain cells to degenerate gradually. In 1872, a physician called George Huntington detailed the illness as inherited chorea. As a result, it was previously known as Huntington's chorea or HC. Huntington's disease generally manifests itself in maturity between the ages of 30 and 40. If the signs of the disease appear before the age of 20, the condition is known as adolescent Huntington's disease. This condition can affect both males and women. According to studies, one out of every 10,000 persons in America has HD, and over 250,000 people are in danger of acquiring the condition from a parent. Affected individuals have a wide variety of symptoms as a result of the condition. It mainly causes problems with motor coordination (movement), intelligence (thinking), and behavior. Deficiencies in muscle movement, as well as the beginning of uncontrolled, uncontrollable jerks, are examples of motor disorders. People with HD also exhibit muscular issues such as contraction (dystonia) or stiffness, as well as decreased walking, balance, and posture. Loss of motor coordination interferes with a person's everyday activities and makes it difficult to live a normal life. Communication and breathing issues are also caused by the condition (dysphagia). Inevitable arise when the motor or cognitive control centers accountable for these activities are damaged. Depression, caused by brain damage and changes in brain function, is a severe behavior and cognition issue linked with Huntington's disease. Huntington's disease is characterized by mental, intellectual, and motor impairments, as well as a number of symptoms and signs. Huntington's disease is connected with cognitive impairments such as a lack of stability, issues remembering, and a lack of impulsive behavior, leading to sexual instability. Muscle issues, aberrant head movements, and difficulty with the physical articulation of speech and feeding aresymptoms of Huntington's disease movement abnormalities. Depression is the most frequent psychological illness linked with Huntington's disease. Depression develops due to brain damage and associated alterations in brain function.

Market Dynamics:

Get an overview of this study by requesting a free sample

Drivers:
  • Increasing Adoption of Enhanced Medicines and Treatments to Fuel Demand for Treatment Options.

The engagement of leading industry participants in the hunt for a treatment for Huntington's disease (HD) is expected to drive market expansion. This can be due to the growing population of patients and illness prevalence worldwide, particularly in North America and Europe. The unmet need for disease-modifying medications and other therapeutic approaches for HD is expected to have a beneficial influence on market growth.

  • Expanding Research and Development Efforts to Accelerate Market Growth.

Because there is no cure or therapy for Huntington's disease, there is a vast opportunity for the study and development of therapeutic options. This is expected to boost market growth throughout the forecast period considerably. Furthermore, prospective government programs promoting the development of novel pharmaceuticals are expected to be another driver boosting market expansion.

Restraints:
  • Drugs are in short supply, which is impeding the market growth.

Because of tight standards and restrictions, the number of licensed medications for Huntington's disease is restricted. This is expected to stifle market expansion throughout the projected period. Moreover, the low level of awareness about this disease in many regions of the world, due to stigma associated with Huntington's disease, strict drug approval restrictions, alternative therapy plans, and a limited number of approved drugs are expected to limit the growth of the Huntington's disease treatment market.

Segmentation Analysis:

The global Huntington’s disease treatment market has been segmented based on drug type, treatment, and regions.

  • The drug type segment is divided into antidepressants, tetrabenazine, tranquilizers, antipsychotic drugs, and others. In 2021, the antidepressants type dominated the market with the largest market share of 24%. Antidepressants are medical drugs that can help ease depression symptoms, social anxiety, anxiety symptoms, clinical depression, dysthymia (mild chronic depression), and other ailments. The primary goal of antidepressant treatment is to ease the symptoms of severe depression, including such as feeling depressed and weary, and to keep them from recurring. They are intended to restore the mental stability and assist in returning to daily responsibilities. They are also used to treat symptoms such as uneasiness, anxiety, and insomnia issues, as well as to prevent suicide ideation.
  • The treatment segment is divided into disease-modifying therapies and symptomatic treatment. In 2021, disease-modifying therapies accounted for the largest share of the market, with 56.2%. This is due to an increase in disease-modifying therapy R&D, as well as an increase in demand for sophisticated goods such as regenerative medicine and stem cell treatments. Supportive government measures, such as the United States FDA's Fast Track Designation for expediting the registration procedure, may boost the industry.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North American region emerged as the largest market for the global Huntington’s disease treatment market with a 36.4% share of the market revenue in 2021.

  • This rise is attributed to the illness's high burden, higher healthcare investment, increasing research and development efforts in the region, technical breakthroughs, aggressive government measures, and improved patient knowledge regarding Huntington's disease treatment solutions.

North American Region Huntington’s disease treatment Market Share in 2021 - 36.4%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global Huntington’s disease treatment industry.

Spark Therapeutics, Inc., an affiliate of F Hoffmann La Roche Ltd) will collaborate with NeuExcell Therapeutics Inc in September 2021 to research genetic therapy for treating Huntington's disease patients. NeuExcell Therapeutics will earn upfront licensing fees, Research and innovation milestone payouts, and commercial royalties totaling up to USD 190 million as part of the agreement.

Prilenia Therapeutics BV stated its intention to deliver phase 3 data for contender pridopidine at the HC Walkewright 23rd Annual Global Investment Summit, the Cantor Virtual Global Healthcare Convention, and the European Huntington Disease Network in September 2021. A health convention is an excellent way to broaden the consumer base.

List of Key Market Players:

  • Alnylam Pharmaceuticals Inc.
  • GlaxoSmithKline
  • Prana Biotechnology Limited
  • AmpliPhi Biosciences Corp.
  • SOM Biotech
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer
  • Cortex Pharmaceuticals Inc
  • Vertex Pharmaceuticals Incorporated
  • Valeant Pharmaceuticals International Inc.
  • Auspex Pharmaceuticals
  • Raptor Pharmaceutical

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities
  • Consulting And Research Firm

Report Description:

  • Global Huntington’s disease treatment Market, Industry Analysis, Trends, Analysis and Forecast, 2022 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2021 is considered as the base year of the report. 2019 and 2020 are regarded as the historical years, and 2022 to 2030 are the forecast years. The global Huntington's disease treatment market is based on revenue (USD Million). The report incorporates the market study based on income. The study covers the market share revenue/market share/volume for each of the segments, regions, and countries catering to the global Huntington's disease treatment market. The analyzed areas for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses the relative data & information, which have been validated by the leading industry professionals and experts across the globe. The research report also delivers an outline of the attractiveness of Huntington's disease treatment based on drug type, treatment, and regions which are deduced and formulated based on their growth rate (CAGR), market size, and attractiveness by analyzing the present and prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by critical organizations catering to the global Huntington's disease treatment market. This offers vital and in-depth insights to depict the overall market scenario.
  • The report offers a detailed study for the company profiles of key organizations operating in the global Huntington's disease treatment market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and critical financial information. This helps in evaluating the overall competition present in the market scenario.
  • The report provides an elaborative assessment of porter's five forces analysis coupled with SWOT analysis to offer business-related data and pieces of information. Porter's five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development, which influences the company's growth and development to sustain and survive in the long run.
  • Along with that, the report also focuses on the market-related driving factors, growth limitations (restraints), potential industry opportunities, significant trends, and development which act as a critical potential for the investors.
  • Potential growth prospects, along with the penetration rate analysis of the product (market-related, i.e., global Huntington's disease treatment market), are covered to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the Huntington’s disease treatment market was valued at USD 373 million in 2021 to USD 1812.15 million by 2030.

Global Huntington’s disease treatment market is growing at a CAGR of 19.2% during the forecast period 2022-2030.

The global Huntington’s disease treatment market has been segmented based on drug type, treatment, and regions. In 2021, the antidepressants type dominated the market with the largest market share.

North American region emerged as the largest market for the Huntington’s disease treatment.

The market's growth will be influenced by increasing adoption of enhanced medicines and treatments to fuel demand for treatment options and expansion research and development efforts.

Key players are Alnylam Pharmaceuticals Inc., GlaxoSmithKline, Prana Biotechnology Limited, AmpliPhi Biosciences Corp., SOM Biotech, Teva Pharmaceutical Industries Ltd., Pfizer, Cortex Pharmaceuticals Inc.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Drug Type
          4.3.2. Market Attractiveness Analysis By Treatment
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing Adoption of Enhanced Medicines and Treatments to Fuel Demand for Treatment Options
          5.2.2. Expanding Research and Development Efforts
    5.3. Restraints
          5.3.1. Short supply of drugs.

6. Global Huntington’s Disease Treatment Market Analysis and Forecast, By Drug Type
    6.1. Segment Overview
    6.2. Antidepressants
    6.3. Tetrabenazine
    6.4. Tranquilizers
    6.5. Antipsychotic Drugs
    6.6. Others

7. Global Huntington’s Disease Treatment Market Analysis and Forecast, By Treatment
    7.1. Segment Overview
    7.2. Disease-Modifying Therapies
    7.3. Symptomatic Treatment

8. Global Huntington’s Disease Treatment Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Huntington’s Disease Treatment Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Huntington’s Disease Treatment Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Alnylam Pharmaceuticals Inc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Component Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. GlaxoSmithKline
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Component Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Prana Biotechnology Limited
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Component Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. AmpliPhi Biosciences Corp
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Component Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. SOM Biotech
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Component Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Teva Pharmaceutical Industries Ltd
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Component Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Pfizer
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Component Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Cortex Pharmaceuticals Inc
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Component Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Vertex Pharmaceuticals Incorporated
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Component Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Valeant Pharmaceuticals International Inc
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Component Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Auspex Pharmaceuticals
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Component Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Raptor Pharmaceutical
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Component Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
 

List of Table

1. Global Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

2. Global Antidepressants Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

3. Global Tetrabenazine Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

4. Global Tranquilizers Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

5. Global Antipsychotic Drugs Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

6. Global Others Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million)

7. Global Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

8. Global Disease-Modifying Therapies Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

9. Global Symptomatic Treatment Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

10. Global Huntington’s Disease Treatment Market, By Region, 2019-2030 (USD Million) 

11. North America Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

12. North America Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

13. U.S. Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

14. U.S. Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

15. Canada Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

16. Canada Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

17. Mexico Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

18. Mexico Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

19. Europe Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

20. Europe Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

21. Germany Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

22. Germany Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

23. France Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

24. France Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

25. U.K. Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

26. U.K. Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

27. Italy Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

28. Italy Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

29. Spain Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

30. Spain Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

31. Asia Pacific Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

32. Asia Pacific Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

33. Japan Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

34. Japan Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

35. China Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

36. China Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

37. India Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

38. India Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

39. South America Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

40. South America Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

41. Brazil Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

42. Brazil Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

43. Middle East and Africa Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

44. Middle East and Africa Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

45. UAE Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

46. UAE Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

47. South Africa Huntington’s Disease Treatment Market, By Drug Type, 2019-2030 (USD Million) 

48. South Africa Huntington’s Disease Treatment Market, By Treatment, 2019-2030 (USD Million) 

List of Figures 

1. Global Huntington’s Disease Treatment Market Segmentation

2. Huntington’s Disease Treatment Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Huntington’s Disease Treatment Market Attractiveness Analysis By Drug Type

9. Global Huntington’s Disease Treatment Market Attractiveness Analysis By Treatment

10. Global Huntington’s Disease Treatment Market Attractiveness Analysis By Region

11. Global Huntington’s Disease Treatment Market: Dynamics

12. Global Huntington’s Disease Treatment Market Share By Drug Type (2022 & 2030)

13. Global Huntington’s Disease Treatment Market Share By Treatment (2022 & 2030)

14. Global Huntington’s Disease Treatment Market Share by Regions (2022 & 2030)

15. Global Huntington’s Disease Treatment Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global Huntington’s disease treatment market based on below mentioned segments:

Global Huntington’s disease treatment Market by Technology:

  • Antidepressants
  • Tetrabenazine
  • Tranquilizers
  • Antipsychotic Drugs
  • Others

Global Huntington’s disease treatment Market by Type:

  • Disease-Modifying Therapies
  • Symptomatic Treatment

Global Huntington’s disease treatment Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date